Possemis, N., Caldenhove, S., Sambeth, A., & Blokland, A. (2024). Acute Treatment with the Nootropic CILTEP® Does Not Improve Cognitive Performance in Healthy Middle-Aged Participants. Journal of Cognitive Enhancement, 8(1-2), 95-106. https://doi.org/10.1007/s41465-024-00288-z
Possemis, N., Verhey, F., Prickaerts, J., Blokland, A., & Ramakers, I. (2024). A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial. Trials, 25(1), Article 162. https://doi.org/10.1186/s13063-024-08001-3
Zhao, H., Blokland, A., Prickaerts, J., Havekes, R., & Heckman, P. R. A. (2024). Treatment with the selective PDE4B inhibitor A-33 or PDE4D inhibitor zatolmilast prevents sleep deprivation-induced deficits in spatial pattern separation. Behavioural Brain Research, 459, Article 114798. https://doi.org/10.1016/j.bbr.2023.114798
Possemis, N., Ter Huurne, D., Banning, L., Gruters, A., Van Asbroeck, S., König, A., Linz, N., Tröger, J., Langel, K., Blokland, A., Prickaerts, J., de Vugt, M., Verhey, F., & Ramakers, I. (2024). The Reliability and Clinical Validation of Automatically-Derived Verbal Memory Features of the Verbal Learning Test in Early Diagnostics of Cognitive Impairment. Journal of Alzheimer's Disease, 97(1), 179-191. https://doi.org/10.3233/JAD-230608
Blokland, A., Jackson, M., Puustinen, K., Soeterboek, J., & Heckman, P. R. A. (2024). Acute sleep loss impairs object but not spatial pattern separation in humans. Neuroscience Letters, 818, Article 137535. https://doi.org/10.1016/j.neulet.2023.137535
Kloft, L., Otgaar, H., Blokland, A., van Oorsouw, K., Schepers, J., Steinmeyer, S., & Ramaekers, J. G. (2023). False Memories in the Field: Impact of Substance Intoxication and Sleep Restriction on False Memory Formation. Journal of Applied Research in Memory and Cognition, 12(3), 389-400. https://doi.org/10.1037/mac0000055
Handels, R., Grimm, S., Blokland, A., Possemis, N., Ramakers, I., Sambeth, A., Verhey, F., Vos, S., Joore, M., Prickaerts, J., & Jönsson, L. (2023). The value of maintaining cognition in patients with mild cognitive impairment: The innovation headroom and potential cost-effectiveness of roflumilast. Alzheimer's & Dementia, 19(8), 3458-3471. https://doi.org/10.1002/alz.13001
Khairuddin, S., Lim, W. L., Aquili, L., Tsui, K. C., Tse, A. C.-K., Jayalath, S., Varma, R., Sharp, T., Benazzouz, A., Steinbusch, H., Blokland, A., Temel, Y., & Lim, L. W. (2023). Prelimbic Cortical Stimulation Induces Antidepressant-like Responses through Dopaminergic-Dependent and -Independent Mechanisms. Cells, 12(11), Article 1449. https://doi.org/10.3390/cells12111449
Blokland, A. (2023). Can placebo or nocebo pills improve or impair cognition performance?Human psychopharmacology, 38(3), Article e2869. https://doi.org/10.1002/hup.2869
Poon, C. H., Wong, S. T. N., Roy, J., Wang, Y., Chan, H. W. H., Steinbusch, H., Blokland, A., Temel, Y., Aquili, L., & Lim, L. W. (2023). Sex Differences between Neuronal Loss and the Early Onset of Amyloid Deposits and Behavioral Consequences in 5xFAD Transgenic Mouse as a Model for Alzheimer's Disease. Cells, 12(5), Article 780. https://doi.org/10.3390/cells12050780